From Pharma to Farm: Can CRISPR Feed the World?
Now in its second decade, CRISPR genome editing technology is being used to revolutionize agriculture—just in time to help us adapt to climate change
making our daily life easier
for scientific projects
for future generations
Now in its second decade, CRISPR genome editing technology is being used to revolutionize agriculture—just in time to help us adapt to climate change
“We’ve shown that you can biofortify tomatoes with provitamin D3 using gene editing, which means tomatoes could be developed as a plant-based, sustainable source of vitamin D3,” ...
Pfizer said today it will open its first U.S. sites for a global Phase III trial assessing its fordadistrogene movaparvovec (PF-06939926) in Duchenne muscular dystrophy (DMD) after the FDA lifted a clinical hold on the company’s investigational new drug (IND) application for the program, which was imposed in December 2021 after a patient died in a Phase Ib open-label study of the mini-dystrophin gene therapy candidate.
CRISPR is the " Future of Medicine". Millions of lives can be saved if we can declare war on these diseases and speed up the process of more clinical trials. This is why we need funding to advance the cure. Many are borrowing money, creating bond funds and begging donors for the funding needed to advance this discovery. The future of Crispr technology is forecast to be in the billions of dollars in the coming years.
Crisprcoin is the future. The newest cryptocurency is not just about money, it’s about funding research to find cures for diseases that up until now have been incurable. The initial offering of Crispercoin will begin as soon as we raise enough funding for proper security to launch. Monies raised will be donated to research facilities around the country and to cover basic overhead of this project. Raising money through Crisprcoin funding will speed up active research in Genome editing so that lives can be saved and future diseases eliminated. Rewrite the code of life by donating to Crisprcoin today!
Rare diseases affect 1 in 10 Americans, 30 million people in the United States and 350 million globally. 7,000 rare diseases exist and approximately 80 percent are caused by faulty genes.